• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质干细胞衍生的分泌组在帕金森病中的作用研究进展。

Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.

机构信息

Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

出版信息

Int J Mol Sci. 2020 Jul 23;21(15):5241. doi: 10.3390/ijms21155241.

DOI:10.3390/ijms21155241
PMID:32718092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7432166/
Abstract

Mesenchymal stem cell (MSC)-derived secretome demonstrated therapeutic effects like those reported after MSCs transplantation. MSC-derived secretome may avoid various side effects of MSC-based therapy, comprising undesirable differentiation of engrafted MSCs and potential activation of the allogeneic immune response. MSC-derived secretome comprises soluble factors and encapsulated extravesicles (EVs). MSC-derived EVs comprise microvesicles, apoptotic bodies, and exosomes. In this review, we focus on the recent insights into the effects of MSC-derived secretome in Parkinson's disease (PD). In particular, MSC-derived secretome and exosomal components counteracted neuroinflammation and enhanced antioxidant capacity and neurotrophic factors expression. In light of the insights reported in this review, MSC-derived secretome or their released exosomes may be used as a potential therapeutic approach or as adjuvant therapy to counteract the disease progression and improve PD symptoms. Also, MSC-derived secretome may be used as a vehicle in cell transplantation approaches to enhance the viability and survival of engrafted cells. Furthermore, since exosomes can cross the blood-brain barrier, they may be used as biomarkers of neural dysfunction. Further studies are necessary to fully characterize the bioactive molecules present in the secretome and to create a new, effective, cell-free therapeutic approach towards a robust clinical outcome for PD patients.

摘要

间充质干细胞(MSC)衍生的 secretome 表现出与 MSC 移植后报道的类似的治疗效果。MSC 衍生的 secretome 可能避免了基于 MSC 治疗的各种副作用,包括植入的 MSCs 的不良分化和同种异体免疫反应的潜在激活。MSC 衍生的 secretome 包括可溶性因子和封装的外泌体(EVs)。MSC 衍生的 EVs 包括微泡、凋亡小体和外泌体。在这篇综述中,我们重点介绍了 MSC 衍生的 secretome 在帕金森病(PD)中的最新作用。特别是,MSC 衍生的 secretome 和外泌体成分对抗神经炎症,增强抗氧化能力和神经营养因子表达。鉴于本综述中报道的见解,MSC 衍生的 secretome 或其释放的外泌体可作为一种潜在的治疗方法或辅助治疗方法,以对抗疾病进展并改善 PD 症状。此外,MSC 衍生的 secretome 可用作细胞移植方法中的载体,以提高植入细胞的活力和存活率。此外,由于外泌体可以穿过血脑屏障,因此它们可以用作神经功能障碍的生物标志物。需要进一步的研究来充分表征 secretome 中存在的生物活性分子,并创建一种新的、有效的、无细胞的治疗方法,以实现 PD 患者的强大临床结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda6/7432166/44f516bf558e/ijms-21-05241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda6/7432166/f8080d10336e/ijms-21-05241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda6/7432166/44f516bf558e/ijms-21-05241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda6/7432166/f8080d10336e/ijms-21-05241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda6/7432166/44f516bf558e/ijms-21-05241-g002.jpg

相似文献

1
Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.间质干细胞衍生的分泌组在帕金森病中的作用研究进展。
Int J Mol Sci. 2020 Jul 23;21(15):5241. doi: 10.3390/ijms21155241.
2
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.人骨髓间充质干细胞分泌组对帕金森病大鼠模型脑结构和动物行为的影响。
Stem Cells Transl Med. 2017 Feb;6(2):634-646. doi: 10.5966/sctm.2016-0071. Epub 2016 Sep 22.
3
Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?间质干细胞衍生的外泌体:帕金森病的一种新的可能治疗策略?
Cells. 2019 Feb 2;8(2):118. doi: 10.3390/cells8020118.
4
Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.间充质干细胞分泌组的治疗潜力的分子机制。
Cells. 2019 May 16;8(5):467. doi: 10.3390/cells8050467.
5
The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against Parkinson's disease.外泌体在发病机制中的作用及间充质干细胞来源的外泌体治疗帕金森病的疗效。
Neurol Sci. 2023 Jul;44(7):2277-2289. doi: 10.1007/s10072-023-06706-y. Epub 2023 Mar 23.
6
Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.水凝胶包埋脂肪间充质干细胞分泌的细胞外囊泡可对抗帕金森病相关毒素 6-羟多巴胺。
Eur J Pharm Biopharm. 2017 Dec;121:113-120. doi: 10.1016/j.ejpb.2017.09.014. Epub 2017 Sep 28.
7
Neuroprotection by Human Dental Pulp Mesenchymal Stem Cells: From Billions to Nano.牙髓间充质干细胞的神经保护作用:从数十亿到纳米。
Curr Gene Ther. 2018;18(5):307-323. doi: 10.2174/1566523218666180913152615.
8
Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration.牙髓间充质干细胞分泌组:神经保护和神经再生的一种有吸引力的方法。
Int J Mol Sci. 2021 Dec 31;23(1):456. doi: 10.3390/ijms23010456.
9
Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury.间充质基质细胞衍生的富含外泌体的分离分泌组在肝损伤中具有肝保护作用。
Stem Cell Res Ther. 2018 Feb 6;9(1):31. doi: 10.1186/s13287-017-0752-6.
10
Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy.外泌体与干细胞在退行性疾病诊断与治疗中的应用
Cell Transplant. 2018 Mar;27(3):349-363. doi: 10.1177/0963689717723636. Epub 2018 Apr 25.

引用本文的文献

1
Stem cell extracellular vesicles: a new dawn for anti-inflammatory treatment of neurodegenerative diseases.干细胞外泌体:神经退行性疾病抗炎治疗的新曙光。
Front Aging Neurosci. 2025 Jul 11;17:1592578. doi: 10.3389/fnagi.2025.1592578. eCollection 2025.
2
Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson's disease: A systematic review of preclinical studies.间充质干细胞衍生的细胞外囊泡治疗帕金森病的有效性:临床前研究的系统评价
World J Stem Cells. 2025 Apr 26;17(4):102421. doi: 10.4252/wjsc.v17.i4.102421.
3
Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Treatment of Parkinson's Disease.

本文引用的文献

1
The Relationship between Side of Onset and Cerebral Regional Homogeneity in Parkinson's Disease: A Resting-State fMRI Study.帕金森病发病部位与脑区同质性的关系:一项静息态功能磁共振成像研究
Parkinsons Dis. 2020 Jun 27;2020:5146253. doi: 10.1155/2020/5146253. eCollection 2020.
2
Comparative study between bone marrow mesenchymal stem cell and their conditioned medium in the treatment of rat model of Parkinsonism.骨髓间充质干细胞及其条件培养基治疗帕金森病大鼠模型的比较研究。
J Cell Physiol. 2021 Jan;236(1):440-457. doi: 10.1002/jcp.29872. Epub 2020 Jun 17.
3
Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential.
间充质干细胞衍生的细胞外囊泡在帕金森病治疗中的治疗潜力
Cells. 2025 Apr 16;14(8):600. doi: 10.3390/cells14080600.
4
Intranasal administration of tissue inhibitor of metalloproteinase 1 extracted from stem cells from human exfoliated deciduous teeth-conditioned medium improves neurological outcomes and alpha-synuclein elimination in Parkinson's disease mice.经鼻给予从人脱落乳牙干细胞条件培养基中提取的金属蛋白酶组织抑制剂1可改善帕金森病小鼠的神经功能结果并促进α-突触核蛋白清除。
J Dent Sci. 2025 Apr;20(2):1043-1051. doi: 10.1016/j.jds.2024.11.029. Epub 2024 Dec 12.
5
Bone marrow mesenchymal stem cells promote uterine healing by activating the PI3K/AKT pathway and modulating inflammation in rat models.骨髓间充质干细胞通过激活PI3K/AKT信号通路和调节炎症促进大鼠模型子宫愈合。
World J Stem Cells. 2025 Jan 26;17(1):98349. doi: 10.4252/wjsc.v17.i1.98349.
6
Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia.帕金森病中的神经炎症:聚焦于微小RNA与小胶质细胞之间的关系
Front Cell Neurosci. 2024 Jul 26;18:1429977. doi: 10.3389/fncel.2024.1429977. eCollection 2024.
7
miRNA-21-5p is an important contributor to the promotion of injured peripheral nerve regeneration using hypoxia-pretreated bone marrow-derived neural crest cells.微小RNA-21-5p是利用缺氧预处理的骨髓源性神经嵴细胞促进损伤周围神经再生的重要因素。
Neural Regen Res. 2025 Jan 1;20(1):277-290. doi: 10.4103/1673-5374.390956. Epub 2023 Dec 15.
8
Isolation and usage of exosomes in central nervous system diseases.中枢神经系统疾病中外泌体的分离与应用。
CNS Neurosci Ther. 2024 Mar;30(3):e14677. doi: 10.1111/cns.14677.
9
Potential Therapeutic Application and Mechanism of Action of Stem Cell-Derived Extracellular Vesicles (EVs) in Systemic Lupus Erythematosus (SLE).干细胞衍生的细胞外囊泡 (EVs) 在系统性红斑狼疮 (SLE) 中的潜在治疗应用和作用机制。
Int J Mol Sci. 2024 Feb 19;25(4):2444. doi: 10.3390/ijms25042444.
10
Can pluripotent/multipotent stem cells reverse Parkinson's disease progression?多能/多潜能干细胞能逆转帕金森病的病情进展吗?
Front Neurosci. 2024 Jan 31;18:1210447. doi: 10.3389/fnins.2024.1210447. eCollection 2024.
源自不同间充质干细胞来源的细胞外囊泡:治疗效果与转化潜力。
Cell Biosci. 2020 May 24;10:69. doi: 10.1186/s13578-020-00427-x. eCollection 2020.
4
Improvement of Impaired Motor Functions by Human Dental Exfoliated Deciduous Teeth Stem Cell-Derived Factors in a Rat Model of Parkinson's Disease.人脱落乳牙干细胞来源因子改善帕金森病大鼠运动功能障碍。
Int J Mol Sci. 2020 May 27;21(11):3807. doi: 10.3390/ijms21113807.
5
Neuroprotective activities of bacopa, lycopene, astaxanthin, and vitamin B12 combination on oxidative stress-dependent neuronal death.假马齿苋、番茄红素、虾青素和维生素B12组合对氧化应激依赖性神经元死亡的神经保护作用。
J Cell Biochem. 2020 Dec;121(12):4862-4869. doi: 10.1002/jcb.29722. Epub 2020 May 25.
6
Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy.间充质干细胞来源的外泌体通过诱导自噬修复帕金森病模型。
Cell Death Dis. 2020 Apr 27;11(4):288. doi: 10.1038/s41419-020-2473-5.
7
Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease.人根尖周囊液间充质干细胞来源的外泌体:在帕金森病中的治疗应用。
Int J Med Sci. 2020 Feb 24;17(5):657-663. doi: 10.7150/ijms.41515. eCollection 2020.
8
Effects of the probiotic formulation SLAB51 in and Parkinson's disease models.SLAB51 益生菌配方对 和 帕金森病模型的影响。
Aging (Albany NY). 2020 Mar 9;12(5):4641-4659. doi: 10.18632/aging.102927.
9
Potential Roles of Exosomes in Parkinson's Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis.外泌体在帕金森病中的潜在作用:从发病机制、诊断、治疗到预后
Front Cell Dev Biol. 2020 Feb 21;8:86. doi: 10.3389/fcell.2020.00086. eCollection 2020.
10
BDNF as a Promising Therapeutic Agent in Parkinson's Disease.BDNF 作为治疗帕金森病的有希望的治疗剂。
Int J Mol Sci. 2020 Feb 10;21(3):1170. doi: 10.3390/ijms21031170.